South Korea
· Delayed Price · Currency is KRW Kyongbo Pharmaceutical Statistics
Total Valuation
KRX:214390 has a market cap or net worth of KRW 119.30 billion. The enterprise value is 213.80 billion.
| Market Cap | 119.30B |
| Enterprise Value | 213.80B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -0.38% in one year.
| Current Share Class | 23.91M |
| Shares Outstanding | 23.91M |
| Shares Change (YoY) | -0.38% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.13% |
| Owned by Institutions (%) | 1.84% |
| Float | 9.13M |
Valuation Ratios
The trailing PE ratio is 51.98.
| PE Ratio | 51.98 |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.48, with an EV/FCF ratio of -12.02.
| EV / Earnings | 93.17 |
| EV / Sales | 0.90 |
| EV / EBITDA | 11.48 |
| EV / EBIT | 34.73 |
| EV / FCF | -12.02 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.08 |
| Quick Ratio | 0.41 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 4.93 |
| Debt / FCF | -5.53 |
| Interest Coverage | 1.75 |
Financial Efficiency
Return on equity (ROE) is 1.59% and return on invested capital (ROIC) is 2.02%.
| Return on Equity (ROE) | 1.59% |
| Return on Assets (ROA) | 1.68% |
| Return on Invested Capital (ROIC) | 2.02% |
| Return on Capital Employed (ROCE) | 5.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.89 |
Taxes
| Income Tax | -334.35M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.27% in the last 52 weeks. The beta is 1.22, so KRX:214390's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -34.27% |
| 50-Day Moving Average | 5,316.80 |
| 200-Day Moving Average | 6,508.85 |
| Relative Strength Index (RSI) | 32.83 |
| Average Volume (20 Days) | 36,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:214390 had revenue of KRW 236.54 billion and earned 2.29 billion in profits. Earnings per share was 95.99.
| Revenue | 236.54B |
| Gross Profit | 83.39B |
| Operating Income | 7.52B |
| Pretax Income | 1.96B |
| Net Income | 2.29B |
| EBITDA | 19.98B |
| EBIT | 7.52B |
| Earnings Per Share (EPS) | 95.99 |
Balance Sheet
The company has 3.91 billion in cash and 98.42 billion in debt, giving a net cash position of -94.51 billion or -3,953.10 per share.
| Cash & Cash Equivalents | 3.91B |
| Total Debt | 98.42B |
| Net Cash | -94.51B |
| Net Cash Per Share | -3,953.10 |
| Equity (Book Value) | 144.09B |
| Book Value Per Share | 6,026.94 |
| Working Capital | 11.60B |
Cash Flow
In the last 12 months, operating cash flow was -1.42 billion and capital expenditures -16.37 billion, giving a free cash flow of -17.79 billion.
| Operating Cash Flow | -1.42B |
| Capital Expenditures | -16.37B |
| Free Cash Flow | -17.79B |
| FCF Per Share | -744.25 |
Margins
Gross margin is 35.25%, with operating and profit margins of 3.18% and 0.97%.
| Gross Margin | 35.25% |
| Operating Margin | 3.18% |
| Pretax Margin | 0.83% |
| Profit Margin | 0.97% |
| EBITDA Margin | 8.45% |
| EBIT Margin | 3.18% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 1.02%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 1.02% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 52.09% |
| Buyback Yield | 0.38% |
| Shareholder Yield | 1.40% |
| Earnings Yield | 1.92% |
| FCF Yield | -14.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:214390 has an Altman Z-Score of 2.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 3 |